Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: Prevalence and risk factors

Inflammatory Bowel Diseases

Volumn 18, Issue 5, 2012, Pages 844-848

  Banaszkiewicz, Aleksandra ^a   Kowalska Duplaga, Kinga ^b   Pytrus, Tomasz ^c   Pituch, Hanna ^a   Radzikowski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Antibiotic exposure; Crohn's disease; Proton pump inhibitors; Ulcerative colitis

Indexed keywords

PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; COLON DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTERITIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SCREENING TEST; ULCERATIVE COLITIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INFANT; MALE; ODDS RATIO; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84859790321     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21837     Document Type: Article

References (24)

1. Seksik P, Sokol H, Lepage P, et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24(Suppl 3):11-18. (Pubitemid 44326413)
2. Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Gastroenterol Clin N Am. 2009;38:711-738.
3. Issa M, Ananthakrishnan AN, Binion DG. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1432-1442.
4. Musa S, Thomson S, Cowan M, et al. Clostridium difficile and inflammatory bowel disease. Scand J Gastroenterol. 2010;45:261-272.
5. Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345-351. (Pubitemid 46401531)
6. Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339-344. (Pubitemid 46401530)
7. Hojsak I, Misak Z, Kekez AJ et al. Incidence of Clostridium difficile infection in IBD patients compared to oncology and immunocompetent patients. J Crohns Colitis. 2011 (abstract) P38.
8. Pascarella F, Martinelli M, Miele E, et al. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr. 2009;154:854-858.
9. Wultañska D, Banaszkiewicz A, Radzikowski A, et al. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease. Eur J Clin Microbiol Infect Dis. 2010;29:1265-1270.
10. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302-307. (Pubitemid 47101025)
11. Diggs NG, Surawicz CM. Evolving concepts in Clostridium difficile colitis. Curr Gastroenterol Rep. 2009;11:400-405.
12. Aberra FN, Lichtenstein GR. Methods to avoid infections in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:685-695. (Pubitemid 40961083)
13. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1-7.
14. Rousseeuw PJ, Croux C. Alternatives to the median absolute deviation. J Am Stat Assoc. 1993;88:1273-1283.
15. Goodhand JR, Alazawi W, Rampton DS. Systematic review: Clostridium difficile and inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:428-441.
16. Mylonaki M, Langmead L, Pantes A, et al. Entetric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol. 2004;16:775-778. (Pubitemid 39062569)
17. Vaishnavi C. Established and potential risk factors for Clostridium difficile infection. Indian J Med Microbiol. 2009;27:289-300.
18. Meyer AM, Ramzan NN, Loftus EV, et al. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol. 2004;38:772-775. (Pubitemid 39274178)
19. Kochhar R, Ayyagari A, Goenka MK, et al. Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile. J Clin Gastroenterol. 1993;16:26-30. (Pubitemid 23021393)
20. Levine A. Pediatric inflammatory bowel disease: is it different? Dig Dis. 2009;27:212-214.
21. Kelsen JR, Kim J, Latta D, et al. Recurrence rate of Clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:50-55.
22. Bossuyt P, Verhaegen J, van Asche G, et al. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis. 2009;3:4-7.
23. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57:205-210. (Pubitemid 351158048)
24. Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443-1450. (Pubitemid 351813903)